Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Michael Birrer

Concepts (1125)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

The timeline below shows the dates (blue tick marks) of publications associated with Michael Birrer's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Michael Birrer has written about over time.
Proto-Oncogene Proteins c-jun, 49 publications between 1989 and 2011, average publication date November 1998. Transcription Factor AP-1, 28 publications between 1995 and 2013, average publication date September 2001. Gene Expression Regulation, Neoplastic, 77 publications between 1989 and 2021, average publication date July 2007. Humans, 354 publications between 1980 and 2023, average publication date June 2009. Gene Expression Profiling, 51 publications between 2004 and 2021, average publication date February 2011. Antineoplastic Agents, 31 publications between 1992 and 2023, average publication date January 2012. Female, 273 publications between 1988 and 2023, average publication date February 2012. Cystadenocarcinoma, Serous, 41 publications between 2002 and 2023, average publication date August 2012. Ovarian Neoplasms, 203 publications between 1993 and 2023, average publication date April 2013. Endometrial Neoplasms, 28 publications between 1994 and 2023, average publication date November 2013. Neoplasms, Glandular and Epithelial, 30 publications between 2007 and 2018, average publication date January 2014. Peritoneal Neoplasms, 10 publications between 2010 and 2021, average publication date December 2015. Drug Resistance, Neoplasm, 22 publications between 1997 and 2021, average publication date March 2016. Neoplasm Recurrence, Local, 32 publications between 2010 and 2023, average publication date June 2017. Antineoplastic Combined Chemotherapy Protocols, 51 publications between 2009 and 2023, average publication date June 2017. Antibodies, Monoclonal, Humanized, 21 publications between 2011 and 2023, average publication date January 2018. Immunoconjugates, 13 publications between 2016 and 2021, average publication date May 2018. Maytansine, 9 publications between 2016 and 2021, average publication date July 2018.

To see the data from this visualization as text, click here.
Birrer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description